Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by Jovicaon May 19, 2010 2:22pm
345 Views
Post# 17114544

Level 2

Level 2Level 2 Quote
Market Maker Shares Bid Price Ask Price Shares Market Maker
-- 20,000 0.380 0.385 60,000 --
-- 41,000 0.375 0.390 233,500 --
-- 58,000 0.370 0.395 118,000 --
-- 30,000 0.365 0.400 272,000 --
-- 42,500 0.360 0.405 13,000 --
-- 10,000 0.355 0.410 30,000 --
-- 33,500 0.350 0.415 10,000 --
-- 5,000 0.345 0.420 76,500 --
-- 33,000 0.340 0.425 67,000 --
-- 5,000 0.335 0.430 3,500 --
Bullboard Posts